Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||||||||||
2025 | 2024 | 2025 | 2024 | ||||||||||||||||||||
Net sales | $ | 6,456 | $ | 6,112 | $ | 10,873 | $ | 10,604 | |||||||||||||||
Cost of goods sold | 2,932 | 2,918 | 5,274 | 5,468 | |||||||||||||||||||
Research and development expense | 375 | 357 | 710 | 689 | |||||||||||||||||||
Selling, general and administrative expenses | 1,156 | 1,054 | 1,907 | 1,790 | |||||||||||||||||||
Amortization of intangibles | 161 | 174 | 323 | 351 | |||||||||||||||||||
Restructuring and asset related charges - net | 79 | 92 | 101 | 167 | |||||||||||||||||||
Other income (expense) - net | 103 | (113) | 118 | (212) | |||||||||||||||||||
Interest expense | 52 | 66 | 88 | 107 | |||||||||||||||||||
Income (loss) from continuing operations before income taxes | 1,804 | 1,338 | 2,588 | 1,820 | |||||||||||||||||||
Provision for (benefit from) income taxes on continuing operations | 422 | 282 | 539 | 388 | |||||||||||||||||||
Income (loss) from continuing operations after income taxes | 1,382 | 1,056 | 2,049 | 1,432 | |||||||||||||||||||
Income (loss) from discontinued operations after income taxes | (66) | — | (77) | 47 | |||||||||||||||||||
Net income (loss) | 1,316 | 1,056 | 1,972 | 1,479 | |||||||||||||||||||
Net income (loss) attributable to noncontrolling interests | 2 | 3 | 6 | 7 | |||||||||||||||||||
Net income (loss) attributable to Corteva | $ | 1,314 | $ | 1,053 | $ | 1,966 | $ | 1,472 | |||||||||||||||
Basic earnings (loss) per share of common stock: | |||||||||||||||||||||||
Basic earnings (loss) per share of common stock from continuing operations | $ | 2.02 | $ | 1.51 | $ | 2.99 | $ | 2.04 | |||||||||||||||
Basic earnings (loss) per share of common stock from discontinued operations | (0.10) | — | (0.11) | 0.07 | |||||||||||||||||||
Basic earnings (loss) per share of common stock | $ | 1.92 | $ | 1.51 | $ | 2.88 | $ | 2.11 | |||||||||||||||
Diluted earnings (loss) per share of common stock: | |||||||||||||||||||||||
Diluted earnings (loss) per share of common stock from continuing operations | $ | 2.02 | $ | 1.51 | $ | 2.98 | $ | 2.03 | |||||||||||||||
Diluted earnings (loss) per share of common stock from discontinued operations | (0.10) | — | (0.11) | 0.07 | |||||||||||||||||||
Diluted earnings (loss) per share of common stock | $ | 1.92 | $ | 1.51 | $ | 2.87 | $ | 2.10 | |||||||||||||||
Average number of shares outstanding used in earnings (loss) per share (EPS) calculation (in millions) | |||||||||||||||||||||||
Basic | 681.7 | 695.9 | 683.3 | 698.1 | |||||||||||||||||||
Diluted | 683.1 | 698.1 | 684.7 | 700.4 |
June 30, 2025 | December 31, 2024 | June 30, 2024 | ||||||||||||||||||
Assets | ||||||||||||||||||||
Current assets | ||||||||||||||||||||
Cash and cash equivalents | $ | 2,065 | $ | 3,106 | $ | 1,839 | ||||||||||||||
Marketable securities | 76 | 63 | 120 | |||||||||||||||||
Accounts and notes receivable - net | 8,674 | 5,676 | 7,615 | |||||||||||||||||
Inventories | 4,316 | 5,432 | 4,893 | |||||||||||||||||
Other current assets | 873 | 820 | 892 | |||||||||||||||||
Total current assets | 16,004 | 15,097 | 15,359 | |||||||||||||||||
Investment in nonconsolidated affiliates | 134 | 134 | 113 | |||||||||||||||||
Property, plant and equipment | 9,455 | 9,074 | 9,088 | |||||||||||||||||
Less: Accumulated depreciation | 5,302 | 4,975 | 4,933 | |||||||||||||||||
Net property, plant and equipment | 4,153 | 4,099 | 4,155 | |||||||||||||||||
Goodwill | 10,518 | 10,408 | 10,490 | |||||||||||||||||
Other intangible assets | 8,583 | 8,876 | 9,238 | |||||||||||||||||
Deferred income taxes | 449 | 401 | 538 | |||||||||||||||||
Other assets | 1,918 | 1,810 | 1,571 | |||||||||||||||||
Total Assets | $ | 41,759 | $ | 40,825 | $ | 41,464 | ||||||||||||||
Liabilities and Equity | ||||||||||||||||||||
Current liabilities | ||||||||||||||||||||
Short-term borrowings and finance lease obligations | $ | 1,942 | $ | 750 | $ | 2,253 | ||||||||||||||
Accounts payable | 3,828 | 4,039 | 3,300 | |||||||||||||||||
Income taxes payable | 485 | 207 | 488 | |||||||||||||||||
Deferred revenue | 358 | 3,287 | 413 | |||||||||||||||||
Accrued and other current liabilities | 2,903 | 2,103 | 2,499 | |||||||||||||||||
Total current liabilities | 9,516 | 10,386 | 8,953 | |||||||||||||||||
Long-term debt | 1,687 | 1,953 | 2,471 | |||||||||||||||||
Other noncurrent liabilities | ||||||||||||||||||||
Deferred income tax liabilities | 258 | 478 | 607 | |||||||||||||||||
Pension and other post-employment benefits | 2,229 | 2,271 | 2,452 | |||||||||||||||||
Other noncurrent obligations | 1,918 | 1,707 | 1,560 | |||||||||||||||||
Total noncurrent liabilities | $ | 6,092 | $ | 6,409 | $ | 7,090 | ||||||||||||||
Commitments and contingent liabilities | ||||||||||||||||||||
Stockholders' equity | ||||||||||||||||||||
Common stock, $0.01 par value; 1,666,667,000 shares authorized; issued at June 30, 2025 - 679,879,000; December 31, 2024 - 685,595,000; and June 30, 2024 - 693,617,000 | 7 | 7 | 7 | |||||||||||||||||
Additional paid-in capital | 27,014 | 27,196 | 27,504 | |||||||||||||||||
Retained earnings (accumulated deficit) | 1,532 | 55 | 992 | |||||||||||||||||
Accumulated other comprehensive income (loss) | (2,644) | (3,469) | (3,324) | |||||||||||||||||
Total Corteva stockholders' equity | 25,909 | 23,789 | 25,179 | |||||||||||||||||
Noncontrolling interests | 242 | 241 | 242 | |||||||||||||||||
Total equity | 26,151 | 24,030 | 25,421 | |||||||||||||||||
Total Liabilities and Equity | $ | 41,759 | $ | 40,825 | $ | 41,464 |
Six Months Ended June 30, | |||||||||||
2025 | 2024 | ||||||||||
Operating activities | |||||||||||
Net income (loss) | $ | 1,972 | $ | 1,479 | |||||||
(Income) loss from discontinued operations after income taxes | 77 | (47) | |||||||||
Adjustments to reconcile net income (loss) to cash provided by (used for) operating activities: | |||||||||||
Depreciation and amortization | 597 | 619 | |||||||||
Provision for (benefit from) deferred income tax | (209) | (303) | |||||||||
Net periodic pension and OPEB (benefit) cost, net | 19 | 82 | |||||||||
Pension and OPEB contributions | (84) | (95) | |||||||||
Net (gain) loss on sales of property, businesses, consolidated companies and investments | (17) | (17) | |||||||||
Restructuring and asset related charges - net | 101 | 167 | |||||||||
Other net loss | 272 | 245 | |||||||||
Changes in assets and liabilities, net | |||||||||||
Accounts and notes receivable | (2,544) | (2,427) | |||||||||
Inventories | 1,310 | 1,783 | |||||||||
Accounts payable | (356) | (913) | |||||||||
Deferred revenue | (2,944) | (2,978) | |||||||||
Other assets and liabilities | 667 | 406 | |||||||||
Cash provided by (used for) operating activities - continuing operations | $ | (1,139) | $ | (1,999) | |||||||
Cash provided by (used for) operating activities - discontinued operations | (23) | (159) | |||||||||
Cash provided by (used for) operating activities | $ | (1,162) | $ | (2,158) | |||||||
Investing activities | |||||||||||
Capital expenditures | $ | (212) | $ | (262) | |||||||
Proceeds from sales of property, businesses and consolidated companies - net of cash divested | 25 | 20 | |||||||||
Purchases of investments | — | (136) | |||||||||
Proceeds from sales and maturities of investments | 62 | 65 | |||||||||
Proceeds from (payment for) settlement of net investment hedge | (56) | 15 | |||||||||
Other investing activities, net | (17) | (7) | |||||||||
Cash provided by (used for) investing activities | $ | (198) | $ | (305) | |||||||
Financing activities | |||||||||||
Net change in borrowings (less than 90 days) | $ | 28 | $ | 628 | |||||||
Proceeds from debt | 1,214 | 2,559 | |||||||||
Payments on debt | (335) | (943) | |||||||||
Repurchase of common stock | (520) | (504) | |||||||||
Proceeds from exercise of stock options | 70 | 28 | |||||||||
Dividends paid to stockholders | (232) | (223) | |||||||||
Other financing activities, net | (38) | (27) | |||||||||
Cash provided by (used for) financing activities | $ | 187 | $ | 1,518 | |||||||
Effect of exchange rate changes on cash, cash equivalents and restricted cash equivalents | 68 | (72) | |||||||||
Increase (decrease) in cash, cash equivalents and restricted cash equivalents | $ | (1,105) | $ | (1,017) | |||||||
Cash, cash equivalents and restricted cash equivalents at beginning of period | 3,422 | 3,158 | |||||||||
Cash, cash equivalents and restricted cash equivalents at end of period | $ | 2,317 | $ | 2,141 | |||||||
Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||||||||||||||||
SEGMENT NET SALES - SEED | 2025 | 2024 | 2025 | 2024 | ||||||||||||||||||||||
Corn | $ | 2,961 | $ | 2,683 | $ | 5,030 | $ | 4,770 | ||||||||||||||||||
Soybean | 1,257 | 1,317 | 1,562 | 1,609 | ||||||||||||||||||||||
Other oilseeds | 186 | 186 | 409 | 431 | ||||||||||||||||||||||
Other | 133 | 145 | 243 | 272 | ||||||||||||||||||||||
Seed | $ | 4,537 | $ | 4,331 | $ | 7,244 | $ | 7,082 | ||||||||||||||||||
Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||||||||||||||||
SEGMENT NET SALES - CROP PROTECTION | 2025 | 2024 | 2025 | 2024 | ||||||||||||||||||||||
Herbicides | $ | 995 | $ | 946 | $ | 1,855 | $ | 1,832 | ||||||||||||||||||
Insecticides | 436 | 415 | 772 | 788 | ||||||||||||||||||||||
Fungicides | 342 | 250 | 646 | 545 | ||||||||||||||||||||||
Biologicals | 97 | 90 | 181 | 172 | ||||||||||||||||||||||
Other | 49 | 80 | 175 | 185 | ||||||||||||||||||||||
Crop Protection | $ | 1,919 | $ | 1,781 | $ | 3,629 | $ | 3,522 | ||||||||||||||||||
Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||||||||||||||||
GEOGRAPHIC NET SALES - SEED | 2025 | 2024 | 2025 | 2024 | ||||||||||||||||||||||
North America1 | $ | 3,954 | $ | 3,753 | $ | 5,551 | $ | 5,224 | ||||||||||||||||||
EMEA2 | 282 | 251 | 1,108 | 1,169 | ||||||||||||||||||||||
Latin America | 154 | 207 | 339 | 478 | ||||||||||||||||||||||
Asia Pacific | 147 | 120 | 246 | 211 | ||||||||||||||||||||||
Rest of World3 | 583 | 578 | 1,693 | 1,858 | ||||||||||||||||||||||
Net Sales | $ | 4,537 | $ | 4,331 | $ | 7,244 | $ | 7,082 | ||||||||||||||||||
Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||||||||||||||||
GEOGRAPHIC NET SALES - CROP PROTECTION | 2025 | 2024 | 2025 | 2024 | ||||||||||||||||||||||
North America1 | $ | 675 | $ | 647 | $ | 1,288 | $ | 1,263 | ||||||||||||||||||
EMEA2 | 465 | 422 | 1,116 | 1,092 | ||||||||||||||||||||||
Latin America | 518 | 443 | 775 | 687 | ||||||||||||||||||||||
Asia Pacific | 261 | 269 | 450 | 480 | ||||||||||||||||||||||
Rest of World3 | 1,244 | 1,134 | 2,341 | 2,259 | ||||||||||||||||||||||
Net Sales | $ | 1,919 | $ | 1,781 | $ | 3,629 | $ | 3,522 |
Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||||||||||||||||
2025 | 2025 | |||||||||||||||||||||||||
Net Sales (GAAP) | $ | 6,456 | $ | 10,873 | ||||||||||||||||||||||
Add: Impacts from Currency and Portfolio / Other | 83 | 274 | ||||||||||||||||||||||||
Organic Sales (Non-GAAP) | $ | 6,539 | $ | 11,147 | ||||||||||||||||||||||
Three Months Ended June 30, | Six Months Ended June 30, | |||||||||||||||||||||||||
OPERATING EBITDA | 2025 | 2024 | 2025 | 2024 | ||||||||||||||||||||||
Seed | $ | 1,863 | $ | 1,698 | $ | 2,705 | $ | 2,446 | ||||||||||||||||||
Crop Protection | 334 | 255 | 711 | 565 | ||||||||||||||||||||||
Corporate Expenses | (33) | (36) | (63) | (60) | ||||||||||||||||||||||
Operating EBITDA (Non-GAAP) | $ | 2,164 | $ | 1,917 | $ | 3,353 | $ | 2,951 | ||||||||||||||||||
RECONCILIATION OF INCOME (LOSS) FROM CONTINUING OPERATIONS AFTER INCOME TAXES TO OPERATING EBITDA | Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||||||||||||
2025 | 2024 | 2025 | 2024 | |||||||||||||||||||||||
Income (loss) from continuing operations after income taxes (GAAP) | $ | 1,382 | $ | 1,056 | $ | 2,049 | $ | 1,432 | ||||||||||||||||||
Provision for (benefit from) income taxes on continuing operations | 422 | 282 | 539 | 388 | ||||||||||||||||||||||
Income (loss) from continuing operations before income taxes (GAAP) | 1,804 | 1,338 | 2,588 | 1,820 | ||||||||||||||||||||||
Depreciation and amortization | 301 | 312 | 597 | 619 | ||||||||||||||||||||||
Interest income | (31) | (25) | (63) | (60) | ||||||||||||||||||||||
Interest expense | 52 | 66 | 88 | 107 | ||||||||||||||||||||||
Exchange (gains) losses - net1 | 25 | 78 | 52 | 137 | ||||||||||||||||||||||
Non-operating (benefits) costs - net2 | 3 | 30 | 13 | 82 | ||||||||||||||||||||||
Mark-to-market (gains) losses on certain foreign currency contracts not designated as hedges | 43 | (19) | 52 | (18) | ||||||||||||||||||||||
Significant items (benefit) charge3 | (33) | 137 | 26 | 264 | ||||||||||||||||||||||
Operating EBITDA (Non-GAAP) | $ | 2,164 | $ | 1,917 | $ | 3,353 | $ | 2,951 |
PRICE - VOLUME - CURRENCY ANALYSIS | ||||||||||||||||||||||||||
REGION | ||||||||||||||||||||||||||
Q2 2025 vs. Q2 2024 | Percent Change Due To: | |||||||||||||||||||||||||
Net Sales Change (GAAP) | Organic Change1 (Non-GAAP) | Price & | Portfolio / | |||||||||||||||||||||||
$ | % | $ | % | Product Mix | Volume | Currency | Other | |||||||||||||||||||
North America | $ | 229 | 5 | % | $ | 244 | 6 | % | 2 | % | 4 | % | (1) | % | — | % | ||||||||||
EMEA | 74 | 11 | % | 87 | 13 | % | 4 | % | 9 | % | (2) | % | — | % | ||||||||||||
Latin America | 22 | 3 | % | 72 | 11 | % | (7) | % | 18 | % | (8) | % | — | % | ||||||||||||
Asia Pacific | 19 | 5 | % | 24 | 6 | % | 4 | % | 2 | % | (1) | % | — | % | ||||||||||||
Rest of World | 115 | 7 | % | 183 | 11 | % | — | % | 11 | % | (4) | % | — | % | ||||||||||||
Total | $ | 344 | 6 | % | $ | 427 | 7 | % | 1 | % | 6 | % | (1) | % | — | % | ||||||||||
SEED | ||||||||||||||||||||||||||
Q2 2025 vs. Q2 2024 | Percent Change Due To: | |||||||||||||||||||||||||
Net Sales Change (GAAP) | Organic Change1 (Non-GAAP) | Price & | Portfolio / | |||||||||||||||||||||||
$ | % | $ | % | Product Mix | Volume | Currency | Other | |||||||||||||||||||
North America | $ | 201 | 5 | % | $ | 214 | 6 | % | 2 | % | 4 | % | (1) | % | — | % | ||||||||||
EMEA | 31 | 12 | % | 57 | 23 | % | 12 | % | 11 | % | (11) | % | — | % | ||||||||||||
Latin America | (53) | (26) | % | (40) | (19) | % | (2) | % | (17) | % | (7) | % | — | % | ||||||||||||
Asia Pacific | 27 | 23 | % | 30 | 25 | % | 6 | % | 19 | % | (2) | % | — | % | ||||||||||||
Rest of World | 5 | 1 | % | 47 | 8 | % | 5 | % | 3 | % | (7) | % | — | % | ||||||||||||
Total | $ | 206 | 5 | % | $ | 261 | 6 | % | 3 | % | 3 | % | (1) | % | — | % | ||||||||||
CROP PROTECTION | ||||||||||||||||||||||||||
Q2 2025 vs. Q2 2024 | Percent Change Due To: | |||||||||||||||||||||||||
Net Sales Change (GAAP) | Organic Change1 (Non-GAAP) | Price & | Portfolio / | |||||||||||||||||||||||
$ | % | $ | % | Product Mix | Volume | Currency | Other | |||||||||||||||||||
North America | $ | 28 | 4 | % | $ | 30 | 5 | % | 1 | % | 4 | % | (1) | % | — | % | ||||||||||
EMEA | 43 | 10 | % | 30 | 7 | % | (1) | % | 8 | % | 3 | % | — | % | ||||||||||||
Latin America | 75 | 17 | % | 112 | 25 | % | (9) | % | 34 | % | (8) | % | — | % | ||||||||||||
Asia Pacific | (8) | (3) | % | (6) | (2) | % | 3 | % | (5) | % | (1) | % | — | % | ||||||||||||
Rest of World | 110 | 10 | % | 136 | 12 | % | (3) | % | 15 | % | (2) | % | — | % | ||||||||||||
Total | $ | 138 | 8 | % | $ | 166 | 9 | % | (2) | % | 11 | % | (1) | % | — | % |
SEED PRODUCT LINE | ||||||||||||||||||||||||||
Q2 2025 vs. Q2 2024 | Percent Change Due To: | |||||||||||||||||||||||||
Net Sales Change (GAAP) | Organic Change1 (Non-GAAP) | Price & | Portfolio / | |||||||||||||||||||||||
$ | % | $ | % | Product Mix | Volume | Currency | Other | |||||||||||||||||||
Corn | $ | 278 | 10 | % | $ | 321 | 12 | % | 4 | % | 8 | % | (2) | % | — | % | ||||||||||
Soybeans | (60) | (5) | % | (57) | (4) | % | 1 | % | (5) | % | (1) | % | — | % | ||||||||||||
Other oilseeds | — | — | % | 8 | 4 | % | 2 | % | 2 | % | (4) | % | — | % | ||||||||||||
Other | (12) | (8) | % | (11) | (8) | % | 1 | % | (9) | % | — | % | — | % | ||||||||||||
Total | $ | 206 | 5 | % | $ | 261 | 6 | % | 3 | % | 3 | % | (1) | % | — | % | ||||||||||
CROP PROTECTION PRODUCT LINE | ||||||||||||||||||||||||||
Q2 2025 vs. Q2 2024 | Percent Change Due To: | |||||||||||||||||||||||||
Net Sales Change (GAAP) | Organic Change1 (Non-GAAP) | Price & | Portfolio / | |||||||||||||||||||||||
$ | % | $ | % | Product Mix | Volume | Currency | Other | |||||||||||||||||||
Herbicides | $ | 49 | 5 | % | $ | 58 | 6 | % | (2) | % | 8 | % | (1) | % | — | % | ||||||||||
Insecticides | 21 | 5 | % | 29 | 7 | % | (2) | % | 9 | % | (2) | % | — | % | ||||||||||||
Fungicides | 92 | 37 | % | 100 | 40 | % | 2 | % | 38 | % | (3) | % | — | % | ||||||||||||
Biologicals | 7 | 8 | % | 12 | 13 | % | (8) | % | 21 | % | (5) | % | — | % | ||||||||||||
Other | (31) | (39) | % | (33) | (41) | % | (4) | % | (37) | % | 2 | % | — | % | ||||||||||||
Total | $ | 138 | 8 | % | $ | 166 | 9 | % | (2) | % | 11 | % | (1) | % | — | % |
PRICE - VOLUME - CURRENCY ANALYSIS | ||||||||||||||||||||||||||
REGION | ||||||||||||||||||||||||||
First Half 2025 vs. First Half 2024 | Percent Change Due To: | |||||||||||||||||||||||||
Net Sales Change (GAAP) | Organic Change1 (Non-GAAP) | Price & | Portfolio / | |||||||||||||||||||||||
$ | % | $ | % | Product Mix | Volume | Currency | Other | |||||||||||||||||||
North America | $ | 352 | 5 | % | $ | 378 | 6 | % | 2 | % | 4 | % | (1) | % | — | % | ||||||||||
EMEA | (37) | (2) | % | 79 | 3 | % | 2 | % | 1 | % | (5) | % | — | % | ||||||||||||
Latin America | (51) | (4) | % | 68 | 6 | % | (6) | % | 12 | % | (10) | % | — | % | ||||||||||||
Asia Pacific | 5 | 1 | % | 18 | 3 | % | 3 | % | — | % | (2) | % | — | % | ||||||||||||
Rest of World | (83) | (2) | % | 165 | 4 | % | — | % | 4 | % | (6) | % | — | % | ||||||||||||
Total | $ | 269 | 3 | % | $ | 543 | 5 | % | 1 | % | 4 | % | (2) | % | — | % | ||||||||||
SEED | ||||||||||||||||||||||||||
First Half 2025 vs. First Half 2024 | Percent Change Due To: | |||||||||||||||||||||||||
Net Sales Change (GAAP) | Organic Change1 (Non-GAAP) | Price & | Portfolio / | |||||||||||||||||||||||
$ | % | $ | % | Product Mix | Volume | Currency | Other | |||||||||||||||||||
North America | $ | 327 | 6 | % | $ | 343 | 7 | % | 3 | % | 4 | % | (1) | % | — | % | ||||||||||
EMEA | (61) | (5) | % | 31 | 3 | % | 5 | % | (2) | % | (8) | % | — | % | ||||||||||||
Latin America | (139) | (29) | % | (91) | (19) | % | (4) | % | (15) | % | (10) | % | — | % | ||||||||||||
Asia Pacific | 35 | 17 | % | 40 | 19 | % | 8 | % | 11 | % | (2) | % | — | % | ||||||||||||
Rest of World | (165) | (9) | % | (20) | (1) | % | 3 | % | (4) | % | (8) | % | — | % | ||||||||||||
Total | $ | 162 | 2 | % | $ | 323 | 5 | % | 3 | % | 2 | % | (3) | % | — | % | ||||||||||
CROP PROTECTION | ||||||||||||||||||||||||||
First Half 2025 vs. First Half 2024 | Percent Change Due To: | |||||||||||||||||||||||||
Net Sales Change (GAAP) | Organic Change1 (Non-GAAP) | Price & | Portfolio / | |||||||||||||||||||||||
$ | % | $ | % | Product Mix | Volume | Currency | Other | |||||||||||||||||||
North America | $ | 25 | 2 | % | $ | 35 | 3 | % | (1) | % | 4 | % | (1) | % | — | % | ||||||||||
EMEA | 24 | 2 | % | 48 | 4 | % | (1) | % | 5 | % | (2) | % | — | % | ||||||||||||
Latin America | 88 | 13 | % | 159 | 23 | % | (7) | % | 30 | % | (10) | % | — | % | ||||||||||||
Asia Pacific | (30) | (6) | % | (22) | (5) | % | 1 | % | (6) | % | (1) | % | — | % | ||||||||||||
Rest of World | 82 | 4 | % | 185 | 8 | % | (2) | % | 10 | % | (4) | % | — | % | ||||||||||||
Total | $ | 107 | 3 | % | $ | 220 | 6 | % | (2) | % | 8 | % | (3) | % | — | % |
SEED PRODUCT LINE | ||||||||||||||||||||||||||
First Half 2025 vs. First Half 2024 | Percent Change Due To: | |||||||||||||||||||||||||
Net Sales Change (GAAP) | Organic Change1 (Non-GAAP) | Price & | Portfolio / | |||||||||||||||||||||||
$ | % | $ | % | Product Mix | Volume | Currency | Other | |||||||||||||||||||
Corn | $ | 260 | 5 | % | $ | 386 | 8 | % | 3 | % | 5 | % | (3) | % | — | % | ||||||||||
Soybeans | (47) | (3) | % | (42) | (3) | % | 1 | % | (4) | % | — | % | — | % | ||||||||||||
Other oilseeds | (22) | (5) | % | 1 | — | % | 3 | % | (3) | % | (5) | % | — | % | ||||||||||||
Other | (29) | (11) | % | (22) | (8) | % | 5 | % | (13) | % | (3) | % | — | % | ||||||||||||
Total | $ | 162 | 2 | % | $ | 323 | 5 | % | 3 | % | 2 | % | (3) | % | — | % | ||||||||||
CROP PROTECTION PRODUCT LINE | ||||||||||||||||||||||||||
First Half 2025 vs. First Half 2024 | Percent Change Due To: | |||||||||||||||||||||||||
Net Sales Change (GAAP) | Organic Change1 (Non-GAAP) | Price & | Portfolio / | |||||||||||||||||||||||
$ | % | $ | % | Product Mix | Volume | Currency | Other | |||||||||||||||||||
Herbicides | $ | 23 | 1 | % | $ | 70 | 4 | % | (2) | % | 6 | % | (3) | % | — | % | ||||||||||
Insecticides | (16) | (2) | % | 12 | 2 | % | (1) | % | 3 | % | (4) | % | — | % | ||||||||||||
Fungicides | 101 | 19 | % | 128 | 23 | % | (2) | % | 25 | % | (4) | % | — | % | ||||||||||||
Biologicals | 9 | 5 | % | 20 | 12 | % | (6) | % | 18 | % | (7) | % | — | % | ||||||||||||
Other | (10) | (5) | % | (10) | (5) | % | (1) | % | (4) | % | — | % | — | % | ||||||||||||
Total | $ | 107 | 3 | % | $ | 220 | 6 | % | (2) | % | 8 | % | (3) | % | — | % |
SIGNIFICANT ITEMS BY SEGMENT (PRE-TAX) | |||||||||||||||||||||||
Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||||||||||
2025 | 2024 | 2025 | 2024 | ||||||||||||||||||||
Seed | $ | (1) | $ | (31) | $ | (41) | $ | (47) | |||||||||||||||
Crop Protection | 37 | (79) | 23 | (176) | |||||||||||||||||||
Corporate | (3) | (27) | (8) | (41) | |||||||||||||||||||
Total significant items before income taxes | $ | 33 | $ | (137) | $ | (26) | $ | (264) |
SIGNIFICANT ITEMS - PRE-TAX, AFTER TAX, AND EPS IMPACTS | ||||||||||||||||||||||||||||||||||||||
Pre-tax | After tax 9 | ($ Per Share) | ||||||||||||||||||||||||||||||||||||
2025 | 2024 | 2025 | 2024 | 2025 | 2024 | |||||||||||||||||||||||||||||||||
1st Quarter | ||||||||||||||||||||||||||||||||||||||
Restructuring and asset related charges - net 1 | $ | (22) | $ | (75) | $ | (17) | $ | (56) | $ | (0.02) | $ | (0.08) | ||||||||||||||||||||||||||
Estimated settlement expense 2 | — | (54) | — | (41) | — | (0.06) | ||||||||||||||||||||||||||||||||
Gain (loss) on sale of assets 3 | — | 4 | — | 3 | — | 0.01 | ||||||||||||||||||||||||||||||||
Acquisition-related costs 4 | — | (2) | — | (1) | — | — | ||||||||||||||||||||||||||||||||
AltEn facility remediation charges 5 | (37) | — | (28) | — | (0.04) | — | ||||||||||||||||||||||||||||||||
Income tax items 6 | — | — | 55 | — | 0.08 | — | ||||||||||||||||||||||||||||||||
1st Quarter – Total | $ | (59) | $ | (127) | $ | 10 | $ | (95) | $ | 0.02 | $ | (0.13) | ||||||||||||||||||||||||||
2nd Quarter | ||||||||||||||||||||||||||||||||||||||
Restructuring and asset related charges - net 1 | $ | (79) | $ | (92) | $ | (59) | $ | (69) | $ | (0.09) | $ | (0.10) | ||||||||||||||||||||||||||
Estimated settlement expense 2 | — | (47) | — | (36) | — | (0.05) | ||||||||||||||||||||||||||||||||
Inventory write-offs 3 | — | 2 | — | 2 | — | — | ||||||||||||||||||||||||||||||||
Gain (loss) on sale of assets 3 | 14 | 3 | 12 | 2 | 0.02 | — | ||||||||||||||||||||||||||||||||
Acquisition-related costs 4 | — | (3) | — | (2) | — | — | ||||||||||||||||||||||||||||||||
Insurance proceeds 7 | $ | 98 | $ | — | $ | 74 | $ | — | $ | 0.11 | $ | — | ||||||||||||||||||||||||||
2nd Quarter – Total | $ | 33 | $ | (137) | $ | 27 | $ | (103) | $ | 0.04 | $ | (0.15) | ||||||||||||||||||||||||||
Year-to-Date Total 8 | $ | (26) | $ | (264) | $ | 37 | $ | (198) | $ | 0.05 | $ | (0.28) |
Operating Earnings (Loss) Per Share (Non-GAAP) | |||||||||||||||||||||||
Operating earnings (loss) per share is defined as earnings (loss) per share from continuing operations – diluted, excluding the after-tax impact of significant items, the after-tax impact of non-operating benefits (costs), the after-tax impact of amortization expense associated with intangible assets existing as of the Separation from DowDuPont, and the after-tax impact of net unrealized gain or loss from mark-to-market activity for certain foreign currency derivative instruments that do not qualify for hedge accounting. | |||||||||||||||||||||||
Three Months Ended June 30, | |||||||||||||||||||||||
2025 | 2024 | 2025 | 2024 | ||||||||||||||||||||
$ | $ | EPS (diluted) | EPS (diluted) | ||||||||||||||||||||
Income (loss) from continuing operations attributable to Corteva common stockholders (GAAP) | $ | 1,380 | $ | 1,053 | $ | 2.02 | $ | 1.51 | |||||||||||||||
Less: Non-operating benefits (costs), after tax1 | (8) | (21) | (0.01) | (0.03) | |||||||||||||||||||
Less: Amortization of intangibles (existing as of Separation), after tax | (110) | (118) | (0.16) | (0.16) | |||||||||||||||||||
Less: Mark-to-market gains (losses) on certain foreign currency contracts not designated as hedges, after tax | (33) | 15 | (0.05) | 0.02 | |||||||||||||||||||
Less: Significant items benefit (charge), after tax | 27 | (103) | 0.04 | (0.15) | |||||||||||||||||||
Operating Earnings (Loss) (Non-GAAP)2 | $ | 1,504 | $ | 1,280 | $ | 2.20 | $ | 1.83 |
Six Months Ended June 30, | |||||||||||||||||||||||
2025 | 2024 | 2025 | 2024 | ||||||||||||||||||||
$ | $ | EPS (diluted) | EPS (diluted) | ||||||||||||||||||||
Income (loss) from continuing operations attributable to Corteva common stockholders (GAAP) | $ | 2,043 | $ | 1,425 | $ | 2.98 | $ | 2.03 | |||||||||||||||
Less: Non-operating benefits (costs), after tax1 | (16) | (61) | (0.02) | (0.09) | |||||||||||||||||||
Less: Amortization of intangibles (existing as of Separation), after tax | (219) | (235) | (0.32) | (0.34) | |||||||||||||||||||
Less: Mark-to-market gains (losses) on certain foreign currency contracts not designated as hedges, after tax | (40) | 14 | (0.06) | 0.02 | |||||||||||||||||||
Less: Significant items benefit (charge), after tax | 37 | (198) | 0.05 | (0.28) | |||||||||||||||||||
Operating Earnings (Loss) (Non-GAAP)2 | $ | 2,281 | $ | 1,905 | $ | 3.33 | $ | 2.72 |
Operating EBITDA to Operating Earnings (Loss) Per Share | |||||||||||||||||||||||
Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||||||||||
2025 | 2024 | 2025 | 2024 | ||||||||||||||||||||
Operating EBITDA (Non-GAAP)1 | $ | 2,164 | $ | 1,917 | $ | 3,353 | $ | 2,951 | |||||||||||||||
Depreciation | (140) | (138) | (274) | (268) | |||||||||||||||||||
Amortization of intangibles (post Separation) | (18) | (20) | (38) | (43) | |||||||||||||||||||
Interest income | 31 | 25 | 63 | 60 | |||||||||||||||||||
Interest expense | (52) | (66) | (88) | (107) | |||||||||||||||||||
(Provision for) benefit from income taxes on continuing operations before significant items, non-operating benefits (costs), amortization of intangibles (existing as of Separation), mark-to-market gains (losses) on certain foreign currency contracts not designated as hedges, and exchange gains (losses) (Non-GAAP)1 | (443) | (387) | (663) | (581) | |||||||||||||||||||
Base income tax rate from continuing operations (Non-GAAP)1 | 22.3 | % | 22.5 | % | 22.0 | % | 22.4 | % | |||||||||||||||
Exchange gains (losses), after tax2 | (36) | (48) | (66) | (100) | |||||||||||||||||||
Net (income) loss attributable to non-controlling interests | (2) | (3) | (6) | (7) | |||||||||||||||||||
Operating Earnings (Loss) (Non-GAAP)1 | $ | 1,504 | $ | 1,280 | $ | 2,281 | $ | 1,905 | |||||||||||||||
Diluted Shares (in millions) | 683.1 | 698.1 | 684.7 | 700.4 | |||||||||||||||||||
Operating Earnings (Loss) Per Share (Non-GAAP)1 | $ | 2.20 | $ | 1.83 | $ | 3.33 | $ | 2.72 |
Reconciliation of Base Income Tax Rate to Effective Income Tax Rate | |||||||||||||||||||||||
Base income tax rate is defined as the effective income tax rate less the effect of exchange gains (losses), significant items, amortization of intangibles (existing as of Separation), mark-to-market (gains) losses on certain foreign currency contracts not designated as hedges, and non-operating (benefits) costs. | |||||||||||||||||||||||
Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||||||||||
2025 | 2024 | 2025 | 2024 | ||||||||||||||||||||
Income (loss) from continuing operations before income taxes (GAAP) | $ | 1,804 | $ | 1,338 | $ | 2,588 | $ | 1,820 | |||||||||||||||
Add: Significant items (benefit) charge1 | (33) | 137 | 26 | 264 | |||||||||||||||||||
Non-operating (benefits) costs | 3 | 30 | 13 | 82 | |||||||||||||||||||
Amortization of intangibles (existing as of Separation) | 143 | 154 | 285 | 308 | |||||||||||||||||||
Mark-to-market (gains) losses on certain foreign currency contracts not designated as hedges | 43 | (19) | 52 | (18) | |||||||||||||||||||
Less: Exchange gains (losses)2 | (25) | (78) | (52) | (137) | |||||||||||||||||||
Income (loss) from continuing operations before income taxes, significant items, non-operating (benefits) costs, amortization of intangibles (existing as of Separation), mark-to-market (gains) losses on certain foreign currency contracts not designated as hedges, and exchange gains (losses) (Non-GAAP) | $ | 1,985 | $ | 1,718 | $ | 3,016 | $ | 2,593 | |||||||||||||||
Provision for (benefit from) income taxes on continuing operations (GAAP) | $ | 422 | $ | 282 | $ | 539 | $ | 388 | |||||||||||||||
Add: Tax (expenses) benefits on significant items (benefit) charge1 | (6) | 34 | 63 | 66 | |||||||||||||||||||
Tax (expenses) benefits on non-operating (benefits) costs | (5) | 9 | (3) | 21 | |||||||||||||||||||
Tax benefits on amortization of intangibles (existing as of Separation) | 33 | 36 | 66 | 73 | |||||||||||||||||||
Tax benefits on mark-to-market (gains) losses on certain foreign currency contracts not designated as hedges | 10 | (4) | 12 | (4) | |||||||||||||||||||
Tax (expenses) benefits on exchange gains (losses)2 | (11) | 30 | (14) | 37 | |||||||||||||||||||
Provision for (benefit from) income taxes on continuing operations before significant items, non-operating (benefits) costs, amortization of intangibles (existing as of Separation), mark-to-market (gains) losses on certain foreign currency contracts not designated as hedges, and exchange gains (losses) (Non-GAAP) | $ | 443 | $ | 387 | $ | 663 | $ | 581 | |||||||||||||||
Effective income tax rate (GAAP) | 23.4 | % | 21.1 | % | 20.8 | % | 21.3 | % | |||||||||||||||
Significant items, non-operating (benefits) costs, amortization of intangibles (existing as of Separation), and mark-to-market (gains) losses on certain foreign currency contracts not designated as hedges effect | (0.2) | % | 0.7 | % | 2.0 | % | 0.9 | % | |||||||||||||||
Tax rate from continuing operations before significant items, non-operating (benefits) costs, amortization of intangibles (existing as of Separation), and mark-to-market (gains) losses on certain foreign currency contracts not designated as hedges | 23.2 | % | 21.8 | % | 22.8 | % | 22.2 | % | |||||||||||||||
Exchange gains (losses), net effect2 | (0.9) | % | 0.7 | % | (0.8) | % | 0.2 | % | |||||||||||||||
Base income tax rate from continuing operations (Non-GAAP) | 22.3 | % | 22.5 | % | 22.0 | % | 22.4 | % |
Exchange Gains/Losses | |||||||||||||||||||||||
The Company routinely uses foreign currency exchange contracts to offset its net exposures, by currency, related to the foreign currency-denominated monetary assets and liabilities. The objective of this program is to maintain an approximately balanced position in foreign currencies in order to minimize, on an after-tax basis, the effects of exchange rate changes on net monetary asset positions. The hedging program gains (losses) are largely taxable (tax deductible) in the United States (U.S.), whereas the offsetting exchange gains (losses) on the remeasurement of the net monetary asset positions are often not taxable (tax deductible) in their local jurisdictions. The net pre-tax exchange gains (losses) are recorded in other income (expense) - net and the related tax impact is recorded in provision for (benefit from) income taxes on continuing operations in the Consolidated Statements of Operations. | |||||||||||||||||||||||
Three Months Ended June 30, | Six Months Ended June 30, | ||||||||||||||||||||||
2025 | 2024 | 2025 | 2024 | ||||||||||||||||||||
Subsidiary Monetary Position Gain (Loss) | |||||||||||||||||||||||
Pre-tax exchange gain (loss) | $ | (154) | $ | (66) | $ | (201) | $ | (43) | |||||||||||||||
Local tax (expenses) benefits | 14 | 28 | 13 | 18 | |||||||||||||||||||
Net after-tax impact from subsidiary exchange gain (loss) | $ | (140) | $ | (38) | $ | (188) | $ | (25) | |||||||||||||||
Hedging Program Gain (Loss) | |||||||||||||||||||||||
Pre-tax exchange gain (loss) | $ | 129 | $ | (12) | $ | 149 | $ | (94) | |||||||||||||||
Tax (expenses) benefits | (25) | 2 | (27) | 19 | |||||||||||||||||||
Net after-tax impact from hedging program exchange gain (loss) | $ | 104 | $ | (10) | $ | 122 | $ | (75) | |||||||||||||||
Total Exchange Gain (Loss) | |||||||||||||||||||||||
Pre-tax exchange gain (loss) | $ | (25) | $ | (78) | $ | (52) | $ | (137) | |||||||||||||||
Tax (expenses) benefits | (11) | 30 | (14) | 37 | |||||||||||||||||||
Net after-tax exchange gain (loss) | $ | (36) | $ | (48) | $ | (66) | $ | (100) | |||||||||||||||
Non-controlling interest adjustment | — | — | — | 1 | |||||||||||||||||||
Net after-tax exchange gain (loss) attributable to Corteva | $ | (36) | $ | (48) | $ | (66) | $ | (99) | |||||||||||||||